ERG and Cancer
Overexpression of truncated ERG from <em>TMPRSS2-ERG</em> fusion and prostate cancer development
9
The ubiquitin ligase TRIM25 targets ERG for degradation in prostate cancer
11
Functional antagonism of TMPRSS2-ERG splice variants in prostate cancer
12
TMPRSS2-ERG fusion promotes prostate cancer metastases in bone
15
Androgens Induce Functional CXCR4 through ERG Factor Expression in TMPRSS2-ERG Fusion-Positive Prostate Cancer Cells
10
Predictive significance of TMRPSS2-ERG fusion in prostate cancer: a meta-analysis
12
A Prospective Investigation of PTEN Loss and ERG Expression in Lethal Prostate Cancer
10
ERG induces androgen receptor mediated regulation of SOX9 in prostate cancer
15
Detection of TMPRSS2 : ERG fusion gene in circulating prostate cancer cells
7
Presence of TMPRSS2-ERG is associated with alterations of the metabolic profile in human prostate cancer
15
Targeting the ERG oncogene with splice-switching oligonucleotides as a novel therapeutic strategy in prostate cancer
33
TMPRSS2:ERG gene aberrations may provide insight into pT stage in prostate cancer
6
Identification of novel TMPRSS2:ERG mechanisms in prostate cancer metastasis: involvement of MMP9 and PLXNA2
59
Analytical platform evaluation for quantification of ERG in prostate cancer using protein and mRNA detection methods
14
Original Article The oncogenic gene fusion TMPRSS2: ERG is not a diagnostic or prognostic marker for ovarian cancer
7
Loss of miR-449a in ERG-associated prostate cancer promotes the invasive phenotype by inducing SIRT1
16
TMPRSS2â ERG gene fusion is rare compared to PTEN deletions in stage T1a prostate cancer
20
The oncogenic transcription factor ERG represses the transcription of the tumour suppressor gene PTEN in prostate cancer cells
6
Deletion of 3p13 is a late event linked to progression of <em>TMPRSS2:ERG</em> fusion prostate cancer
9
Prostate cancer risk regions at 8q24 and 17q24 are differentially associated with somatic TMPRSS2:ERG fusion status.
36